Mesoblast to develop neuro diseases therapies

Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...

June 11, 2012 | Monday | News
BMS halts Hep C drug administration

Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...

August 2, 2012 | Thursday | News
Starpharma drug targets cancer more effectively

Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...

October 29, 2012 | Monday | News
Eisai, Toyama get marketing approval for iguratimod

Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...

July 2, 2012 | Monday | Regulatory
Jazz Pharma clocks $208 mn in Q2 2013

Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...

August 7, 2013 | Wednesday | Company results
Charles River to acquire Galapagos at USD 179 mn

Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...

March 19, 2014 | Wednesday | News
Chugai, Nippon Shinyaku tie up for drug development

Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co...

December 6, 2012 | Thursday | News
EMA recommends MSD's melanoma drug

Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...

May 27, 2015 | Wednesday | Regulatory
10 top global pharma firms join hands for drug discovery

Singapore: Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development ...

September 20, 2012 | Thursday | News
Nuvilex, Lincoln Park Fund sign $27 mn stock deal

Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment o...

February 21, 2014 | Friday | News
Korea to spend $8.9 bn to develop 20 drugs by 2017

Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the nex...

July 23, 2013 | Tuesday | News
Abbott reveals 10-year study data for HUMIRA

Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (ad...

June 6, 2012 | Wednesday | News
Edinburgh Univ, Biogen to study neuro diseases

Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have join...

July 22, 2013 | Monday | News
Admedus acquires Genzyme manufacturing site

Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...

December 12, 2013 | Thursday | News
AstraZeneca halts development of obesity drug

Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2...

September 10, 2012 | Monday | News
Trajenta shows blood glucose improvements

Singapore: Results from a two-year study has demonstrated that Boehringer Ingelheim's Trajenta (linagliptin) provides si...

July 2, 2012 | Monday | News
One drug for three diseases

VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...

August 1, 2012 | Wednesday | Opinion
China invests $160 bn in biomedicine sector

Singapore: A report filed by Lux Research that tracks emerging technologies has said that China has invested a staggerin...

July 12, 2013 | Friday | News